Sign In
Buy C
$135.13
+5.14 (+3.95%)
At Close: Jun 04, 2026
Lazard hires Citigroup's Miller in energy investment banking push, sources say
01:26pm, Tuesday, 03'rd Dec 2024
Lazard has hired veteran Citigroup investment banker Chris Miller as a managing director to help drive its dealmaking efforts in the energy industry, people familiar with the matter told Reuters on Tu
2 Warren Buffett Stocks to Buy Hand Over Fist in December
10:15am, Tuesday, 03'rd Dec 2024
Warren Buffett and his company, Berkshire Hathaway, have made a name for themselves by generating great returns for decades. That, coupled with the power of time and compounding, has led Berkshire's s
Buffett's November DiviDog Pile Had No 'Safer' Buys
09:34am, Tuesday, 03'rd Dec 2024
Berkshire Hathaway's portfolio includes diverse blue chips and lesser-known growth stocks, with 25 dividend-paying stocks analyzed for yield-based investment opportunities. Top Berkshire dividend stoc
The Smartest Warren Buffett Stocks to Buy With $1,000 Right Now
09:11am, Tuesday, 03'rd Dec 2024
Warren Buffett's long-term success in the stock market is undeniable. Since becoming CEO of Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has delivered 20% annually to its investors.
‘Contrarians aren't being rewarded,' and short sellers of U.S. stocks are giving up, says Citigroup
07:40am, Tuesday, 03'rd Dec 2024
Strategists at Citigroup say investors are increasingly giving up on bets against the U.S. stock market.
Banks hit credit card users with higher rates in response to regulation that may never arrive
07:00am, Tuesday, 03'rd Dec 2024
Banks that issue credit cards used by millions of consumers raised interest rates and introduced new fees in response to an impending regulation that most experts believe will never take effect. Synch
Citigroup (C) Exceeds Market Returns: Some Facts to Consider
06:51pm, Monday, 02'nd Dec 2024
Citigroup (C) closed the most recent trading day at $71.39, moving +0.73% from the previous trading session.
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
04:05pm, Monday, 02'nd Dec 2024
FOSTER CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio
Citigroup Nears Banamex Spin-Off Amid Organizational Overhaul
12:10pm, Monday, 02'nd Dec 2024
C nears divesting Banamex as part of its restructuring efforts to exit the retail banking business in some markets and invest in sectors with high potential.
Billionaire Ken Griffin Is Buying These Warren Buffett Stocks Hand Over Fist. Should You?
05:51am, Friday, 29'th Nov 2024
Warren Buffett and Ken Griffin share a few things in common. First, they're both billionaires and highly respected investors.
A Simpler Citigroup Begins to Take Shape
05:30am, Friday, 29'th Nov 2024
CEO Jane Fraser is moving closer to a spinoff of Mexican consumer bank Banamex.
Citigroup Expands Into Mortgage Market With Investment in Pylon
12:16pm, Thursday, 28'th Nov 2024
C's investment in Pylon will help automate mortgage origination and offer interim funding to consumers until the loans reach the capital markets.
Citigroup to Slash Year-End Promotions Amid Organization Overhaul
11:45am, Wednesday, 27'th Nov 2024
C plans to cut year-end promotions as part of the organizational overhaul plan to achieve cost efficiency.
Citigroup: Still Undervalued As Restructuring Is Showing Results
09:00am, Wednesday, 27'th Nov 2024
Citigroup has appreciated over 50% in the past year, yet still trades at a discount, offering a 3%+ dividend yield and potential for further gains. Under Jane Fraser's leadership, Citigroup has reduce
It's Still Early In The Citigroup Turnaround Story - Buy In Now
01:15am, Wednesday, 27'th Nov 2024
Citigroup's recent financials show stable top-line performance but falling profitability due to ongoing investments in tech and human capital. We expect these investments to pay off over the next few
